Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker.

Oncotarget - 6 Sept 2016

Yu Wei, Ma Yiming, Shankar Sharmila, Srivastava Rakesh K

Abstract excerpt

SATB2 (special AT-rich binding protein-2), a transcription factor and chromatin modulator, regulates the expression of genes required for maintaining pluripotency and self-renewal. The molecular mechanisms by which human pancreatic normal ductal epithelial cells are transformed to cancer cells are not well understood. The main goal of the paper is to examine the molecular mechanisms by which SATB2 regulates...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Dedifferentiation
Share to Chromatin
Share to Epithelial-Mesenchymal Transition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kruppel-Like Factor 4

Share to Matrix Attachment Region Binding Proteins

Share to Mice, Nude

Share to Neoplastic Stem Cells

Share to Pancreas

Source

Open in PubMed Open full text

Identifiers

PMID: 27472393
DOI: 10.18632/oncotarget.10860
PMCID: PMC5295389

Genes

SATB2
XIAP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker.PMID 27472393Read ↗

SATB2 is a novel biomarker and therapeutic target for cancerSemantic proximity Read ↗

Cellular transformation of human mammary epithelial cells by SATB2Semantic proximity Read ↗

Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial–Mesenchymal Transition in Prostate CancerSemantic proximity Read ↗

Oncogenic role of SATB2 in prostate cancer: Regulator of pluripotency, self-renewal and epithelial-mesenchymal transitionSemantic proximity Read ↗

SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cellsSemantic proximity Read ↗

Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.Semantic proximity Read ↗

SATB2 Induces Malignant Transformation and Cancer Stem Cell Characteristics, and Inhibition of Its Expression Reverses Drug Resistance in MesotheliomaSemantic proximity Read ↗

Embryonic stem cell factors and pancreatic cancerSemantic proximity Read ↗

Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic CancerSemantic proximity Read ↗

A novel mutation of SATB2 inhibits odontogenesis of human dental pulp stem cells through Wnt/β-catenin signaling pathway.Semantic proximity Read ↗

BAZ2A-SUV39H1-SMAD2/3-OCT4 regulates stemness, cell cycle exit and chemoresistance in pancreatic ductal adenocarcinomaSemantic proximity Read ↗

SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.